Michael Smith and Site-directed Mutagenesis.

J Assoc Physicians India

Professor (Retired), Department of Medicine, Topiwala National Medical College and Bai Yamunabai Laxman Nair Charitable Hospital; Honorable Physician, Bhatia Hospital, Mumbai, Maharashtra, India.

Published: July 2024

Download full-text PDF

Source
http://dx.doi.org/10.59556/japi.72.0587DOI Listing

Publication Analysis

Top Keywords

michael smith
4
smith site-directed
4
site-directed mutagenesis
4
michael
1
site-directed
1
mutagenesis
1

Similar Publications

With the majority of the U.S. swine industry being generally bounded by social licensing, there is a growing need to understand social perspectives to better adapt to consumer demands.

View Article and Find Full Text PDF

Lung Transplant Outcomes in Recipients of Advanced Age: Are Two Always Better Than One?

J Thorac Cardiovasc Surg

December 2024

Creighton University School of Medicine, Phoenix, Arizona; Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona. Electronic address:

Background: Lung transplantation has become more common in patients aged 65 years and older. We aimed to examine outcomes across age groups and identify risk factors for decreased survival.

Methods: United Network for Organ Sharing data for all primary lung transplants from 1/1/2006 to 3/8/2023 was retrospectively reviewed.

View Article and Find Full Text PDF

Small extracellular vesicles (sEVs) isolated from plasma of lung transplant recipients (LTRs) with chronic lung allograft dysfunction (CLAD) contain increased levels of lung associated self-antigens, Kα1 tubulin and collagen V, and decreased expression of the tumor suppressor liver kinase B1 (LKB1). In this study, sEVs were isolated from plasma collected from LTRs with or without cystic fibrosis (CF) from multiple centers at the onset of CLAD and 6 and 12 months before clinical diagnosis of CLAD (n = 32) as well as from time-matched stable controls (n = 25). sEVs were analyzed for Kα1 tubulin, collagen V, and LKB1 by western blot.

View Article and Find Full Text PDF

Pediatric pulmonary hypertension is a heterogeneous disease associated with significant morbidity and mortality. MicroRNAs have been implicated as both pathologic drivers of disease and potential therapeutic targets in pediatric pulmonary hypertension. We sought to characterize the circulating microRNA profiles of a diverse array of pediatric patients with pulmonary hypertension using high-throughput sequencing technology.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!